108 results
Page 2 of 6
S-3ASR
EX-4.2
46swj8leimk
26 Jul 23
Automatic shelf registration
5:26pm
8-K
EX-99.1
vyfh54
26 Jul 23
Viking Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
4:23pm
8-K
EX-99.1
quq7c2
26 Apr 23
Viking Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
4:06pm
PRE 14A
gsnvz1vn5rw81o0c2t12
17 Apr 23
Preliminary proxy
5:04pm
8-K
EX-1.1
kyra9bvzsr
31 Mar 23
Viking Therapeutics Announces Pricing of $250 Million Public Offering of Common Stock
5:27pm
424B5
x4xz0tz b0
31 Mar 23
Prospectus supplement for primary offering
5:24pm
424B5
94uvwwxxvrx8l87stu3
29 Mar 23
Prospectus supplement for primary offering
4:01pm
8-K
EX-99.1
rtjrvze5n r44kr
26 Oct 22
Viking Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:32pm
8-K
EX-99.1
qi92x
27 Jul 22
Viking Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
4:11pm
8-K
EX-99.1
v7kr9 icwe93j0r6
27 Apr 22
Viking Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update
4:44pm
8-K
EX-99.1
wekgvfm b5ynijr
9 Feb 22
Viking Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Corporate Update
4:15pm